| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | S B Horwitz | |
| P921 | main subject | paclitaxel | Q423762 |
| P304 | page(s) | S3-6 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Taxol (paclitaxel): mechanisms of action | |
| P478 | volume | 5 Suppl 6 |
| Q41018716 | 3D Chemical Similarity Networks for Structure-Based Target Prediction and Scaffold Hopping |
| Q91807491 | 7-epi-Clusianone, a Multi-Targeting Natural Product with Potential Chemotherapeutic, Immune-Modulating, and Anti-Angiogenic Properties |
| Q33787666 | A case of scirrhous gastric cancer with peritonitis carcinomatosa controlled by TS-1 + paclitaxel for 36 mo after diagnosis |
| Q35574714 | A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. |
| Q28541630 | A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cells |
| Q37006660 | Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma |
| Q53692194 | An in vitro demonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugates. |
| Q39029873 | Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice |
| Q52714642 | Anti-apoptotic effects of autophagy via ROS regulation in microtubule-targeted and PDGF-stimulated vascular smooth muscle cells. |
| Q39030222 | Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. |
| Q36544066 | Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway |
| Q38988566 | Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7. |
| Q28649879 | Biodiversity of genes encoding anti-microbial traits within plant associated microbes |
| Q90089128 | Breast Cancer Cells Transition from Mesenchymal to Amoeboid Migration in Tunable Three-Dimensional Silk-Collagen Hydrogels |
| Q30367429 | COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo. |
| Q47151564 | Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival |
| Q26850074 | Cancer wars: natural products strike back |
| Q64906922 | Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation. |
| Q26858839 | Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis |
| Q37072878 | Cloning and characterization of the glycoside hydrolases that remove xylosyl groups from 7-β-xylosyl-10-deacetyltaxol and its analogues |
| Q58599328 | Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment |
| Q34089249 | Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer |
| Q34267632 | Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeutics |
| Q40930626 | Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. |
| Q44910150 | Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines |
| Q38778597 | Costunolide induces G1/S phase arrest and activates mitochondrial-mediated apoptotic pathways in SK-MES 1 human lung squamous carcinoma cells |
| Q33829740 | Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition |
| Q56512260 | Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy |
| Q35016957 | Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy |
| Q90554778 | Differential Morphological and Biochemical Recovery from Chemotherapy-Induced Peripheral Neuropathy Following Paclitaxel, Ixabepilone, or Eribulin Treatment in Mouse Sciatic Nerves |
| Q28569870 | Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis |
| Q92153808 | Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer |
| Q51172732 | Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics. |
| Q41110002 | Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy |
| Q90449258 | Efficacy of Paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer |
| Q37419092 | Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. |
| Q41963392 | Estimation of the diffusion-limited rate of microtubule assembly |
| Q89457930 | Evaluating Inhibitory Effects of Paclitaxel and Vitamin D3 Loaded Poly Lactic Glycolic Acid Co-Delivery Nanoparticles on the Breast Cancer Cell Line |
| Q36609779 | Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients |
| Q45056901 | Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine. |
| Q35318179 | Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity |
| Q56888561 | Force Spectrum Microscopy Using Mitochondrial Fluctuations of Control and ATP-Depleted Cells |
| Q98178571 | Gastrointestinal Motility and Improvement Efficacy of Shenhuang Plaster Application on Shenque: Identification, Evaluation, and Mechanism |
| Q34625514 | Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma |
| Q39777250 | Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). |
| Q33826207 | Impact of vitrification on the meiotic spindle and components of the microtubule-organizing center in mouse mature oocytes |
| Q33753832 | Improving 10-deacetylbaccatin III-10-β-O-acetyltransferase catalytic fitness for Taxol production |
| Q36341381 | Induction of neural differentiation in rat C6 glioma cells with taxol |
| Q58214998 | Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs |
| Q50075745 | Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit |
| Q47099877 | Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells |
| Q50113702 | Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer |
| Q38614408 | Inhibitors of plant hormone transport. |
| Q33921296 | Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. |
| Q41905174 | Integrin imaging to evaluate treatment response |
| Q27319918 | Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy |
| Q38762992 | Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. |
| Q37722656 | Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma |
| Q37467770 | Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. |
| Q47607986 | Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine |
| Q36920871 | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel |
| Q40903523 | Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat. |
| Q36214907 | Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents |
| Q36661727 | Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy |
| Q37849845 | Natural products for cancer chemotherapy |
| Q36291281 | New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex'). |
| Q52685048 | Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors. |
| Q36718459 | PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer |
| Q39721783 | PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle |
| Q57462220 | Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability |
| Q33617851 | Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation. |
| Q36616482 | Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. |
| Q37340395 | Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma |
| Q34656003 | Polymer-drug conjugates: recent development in clinical oncology |
| Q39063012 | Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids |
| Q43199031 | Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms |
| Q92024356 | ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery |
| Q36536262 | Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells |
| Q47095396 | Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells |
| Q37206908 | Recent advances of cocktail chemotherapy by combination drug delivery systems. |
| Q36471409 | Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases |
| Q35602780 | Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles |
| Q28578841 | Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau |
| Q38840499 | Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry |
| Q39309339 | Shedding of phosphatidylserine from developing erythroid cells involves microtubule depolymerization and affects membrane lipid composition |
| Q93079633 | Site occupancy calibration of taxane pharmacology in live cells and tissues |
| Q36926018 | Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy. |
| Q30544130 | Spontaneous migration of cancer cells under conditions of mechanical confinement |
| Q35214722 | Src family kinases and paclitaxel sensitivity |
| Q41811407 | Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases |
| Q37093119 | TLR4 is a novel determinant of the response to paclitaxel in breast cancer |
| Q36995054 | Targeting prostate cancer based on signal transduction and cell cycle pathways. |
| Q33718820 | Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer |
| Q35553616 | The Evolving Role of Docetaxel in the Management of Androgen Independent Prostate Cancer |
| Q57812376 | The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells |
| Q37728992 | The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases |
| Q92480777 | The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation |
| Q26861495 | The Role of TLR4 in Chemotherapy-Driven Metastasis |
| Q36718584 | The diversity of anti-microbial secondary metabolites produced by fungal endophytes: an interdisciplinary perspective |
| Q37091477 | The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer |
| Q37356294 | The p53 breast cancer tissue biomarker in Indian women |
| Q33980966 | The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells |
| Q91906909 | The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling |
| Q26829978 | The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors |
| Q92542925 | Therapeutic and Mechanistic Perspectives of Protein Complexes in Breast Cancer |
| Q55449946 | Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells. |
| Q35053993 | Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. |
| Q27300789 | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
| Q38826784 | Unsuccessful mitosis in multicellular tumour spheroids |
| Q54123535 | Vangl2 regulates spermatid planar cell polarity through microtubule (MT)-based cytoskeleton in the rat testis. |
| Q41074649 | WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death |
| Q57189183 | β-Phenylalanine Ester Synthesis from Stable β-Keto Ester Substrate Using Engineered ω-Transaminases |
Search more.